Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk

Clinical Biochemistry

Volumn 39, Issue 3, 2006, Pages 191-195

  Baum, Larry ^a   Ng, Ho Keung ^a   Woo, Kam Sang ^a   Tomlinson, Brian ^a   Rainer, Timothy Hudson ^a   Chen, Xiangyan ^a   Cheung, Wing Sze ^a   Yin Chan, Daniel Kam ^b   Thomas, G Neil ^c   Wai Tong, Cindy See ^a   Wong, Ka Sing ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Ischemic stroke; Myocardial infarction; Paraoxonase; Polymorphism

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; STROKE;

EID: 33644936372     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.01.010     Document Type: Article

References (24)

1. H.L. Li, D.P. Liu, and C.C. Liang Paraoxonase gene polymorphisms, oxidative stress, and diseases J. Mol. Med. 81 2003 766 779
2. M. Aviram, M. Rosenblat, and C.L. Bisgaier Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase J. Clin. Invest. 101 1998 1581 1590
3. M.I. Mackness, S. Arrol, C. Abbott, and P.N. Durrington Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase Atherosclerosis 104 1993 129 135
4. A.D. Watson, J.A. Berliner, and S.Y. Hama Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein J. Clin. Invest. 96 1995 2882 2891
5. H. Jakubowski Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation J. Biol. Chem. 275 2000 3957 3962
6. B. Mackness, M.I. Mackness, and S. Arrol Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus Atherosclerosis 139 1998 341 349
7. A. Ayub, M.I. Mackness, and S. Arrol Serum paraoxonase after myocardial infarction Arterioscler. Thromb. Vasc. Biol. 19 1999 330 335
8. R. Humbert, D.A. Adler, and C.M. Disteche The molecular basis of the human serum paraoxonase activity polymorphism Nat. Genet. 3 1993 73 76
9. S.M. Herrmann, H. Blanc, and O. Poirier The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study Atherosclerosis 126 1996 299 303
10. Y.L. Ko, Y.S. Ko, and S.M. Wang The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan Atherosclerosis 141 1998 259 264
11. B.T. Heijmans, R.G. Westendorp, and A.M. Lagaay Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects Atherosclerosis 149 2000 91 97
12. Y. Imai, H. Morita, and H. Kurihara Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases Atherosclerosis 149 2000 435 442
13. S. Sen-Banerjee, X. Siles, and H. Campos Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction Arterioscler. Thromb. Vasc. Biol. 20 2000 2120 2126
14. B. Voetsch, K.S. Benke, B.P. Damasceno, L.H. Siqueira, and J. Loscalzo Paraoxonase 192 Gln->Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults Stroke 33 2002 1459 1464
15. G. Zuliani, A. Cherubini, and S. Volpato Genetic factors associated with the absence of atherosclerosis in octogenarians J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 57 2002 M611 M615
16. X. Wang, Z. Fan, and J. Huang Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population Arterioscler. Thromb. Vasc. Biol. 23 2003 328 334
17. D.A. Lawlor, I.N. Day, and T.R. Gaunt The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis BMC Genetics 5 2004 17
18. K.S. Wong, H. Li, and Y.L. Chan Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease Stroke 31 2000 2641 2647
19. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
20. I. Kerridge, L. Lincz, and F. Scorgie Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk Br. J. Haematol. 118 2002 477 481
21. L.F. Lincz, I. Kerridge, and F.E. Scorgie Xenobiotic gene polymorphisms and susceptibility to multiple myeloma Haematologica 89 2004 628 629
22. T.H. Lam, S.Y. Ho, A.J. Hedley, K.H. Mak, and R. Peto Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998 Br. Med. J. 323 2001 361
23. M. Ando, K. Wakai, and N. Seki Attributable and absolute risk of lung cancer death by smoking status: findings from the Japan Collaborative Cohort Study Int. J. Cancer 105 2003 249 254
24. L. Christiansen, L. Bathum, H. Frederiksen, and K. Christensen Paraoxonase 1 polymorphisms and survival Eur. J. Hum. Genet. 12 2004 843 847